SUBROTO BHATTACHARYA: Open Payments
NPI 1053341685 · PEABODY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,307 in 109 payments from 31 companies in 2025. Trend: 2023 $1,792 · 2024 $2,479 · 2025 $2,307
Food & beverage: $2,307
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 15 | $360 |
| Collegium Pharmaceutical, Inc. | 22 | $263 |
| ABBVIE INC. | 8 | $169 |
| Lilly USA, LLC | 6 | $164 |
| PFIZER INC. | 10 | $156 |
| HARMONY BIOSCIENCES LLC | 2 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| Boston Scientific Corporation | 2 | $74 |
Products named: REXULTI, Jornay PM, JARDIANCE, WAKIX, CAPLYTA, TRINTELLIX, NURTEC ODT, MOUNJARO.
Industry payments across MA — which companies pay providers there.
